Alpha-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats
Open Access
- 19 September 2012
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 111
Abstract
Background: Hyperglycemia leads to cardiac oxidative stress and an imbalance in glucose homeostasis. Diabetic cardiomyopathy is characterised by cardiac hypertrophy and fibrosis. However, the underlying mechanisms of diabetic cardiomyopathy are not fully understood. This study aimed to investigate the effects of alpha-lipoic acid (ALA) on cardiac energy metabolism, antioxidant effect, and fibrosis in the hearts of Otsuka Long-Evans Tokushima fatty (OLETF) rats. Methods: Animals were separated into non-diabetic Long-Evans Tokushima Otsuka (LETO) rats and diabetes-prone OLETF rats with or without ALA (200 mg/kg/day) administration for 16 weeks. Diabetic cardiomyopathy was assessed by staining with Sirius Red. The effect of ALA on AMPK signalling, antioxidant enzymes, and fibrosis-related genes in the heart of OLETF rats were performed by Western blot analysis or immunohistochemistry. Results: Western blot analysis showed that cardiac adenosine monophosphate-activated kinase (AMPK) signalling was lower in OLETF rats than in LETO rats, and that ALA treatment increased the signalling in OLETF rats. Furthermore, the low antioxidant activity in OLETF rats was increased by ALA treatment. In addition to increased Sirius red staining of collagen deposits, transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) were expressed at higher levels in OLETF rat hearts than in LETO rat hearts, and the levels of these factors were decreased by ALA. Conclusions: ALA enhances AMPK signalling, antioxidant, and antifibrogenic effect. Theses findings suggest that ALA may have beneficial effects in the treatment of diabetic cardiomyopathy.Keywords
This publication has 51 references indexed in Scilit:
- AMPK in cardiovascular health and diseaseActa Pharmacologica Sinica, 2010
- Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic ratsMetabolism, 2007
- Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in ratsEuropean Journal of Pharmacology, 2006
- Adiponectin-mediated modulation of hypertrophic signals in the heartNature Medicine, 2004
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinaseNature Medicine, 2002
- Metabolic effects of glucose-insulin infusions: myocardium and whole bodyCurrent Opinion in Clinical Nutrition and Metabolic Care, 2001
- AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 1999
- AdipoQ Is a Novel Adipose-specific Gene Dysregulated in ObesityJournal of Biological Chemistry, 1996
- The diabetic heart: metabolic causes for the development of a cardiomyopathyCardiovascular Research, 1992
- Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitusHeart and Vessels, 1985